Rapid development of seizures and PRES in a COVID-19 patient

Neurological dysfunction has been noted in up to 36% of patients hospitalized with COVID-19, and a variety of mechanisms of neurological injury are possible. Here we report the rapid development of PRES and acute seizures in a patient with COVID-19 infection and sickle cell disease. The combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos de Lima, Fabiane, Klein, Sara, El Ammar, Faten, Wu, Shasha, Rose, Sandra, Tao, James X., Issa, Naoum P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931684/
https://www.ncbi.nlm.nih.gov/pubmed/33688630
http://dx.doi.org/10.1016/j.ebr.2021.100436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931684/
https://www.ncbi.nlm.nih.gov/pubmed/33688630
http://dx.doi.org/10.1016/j.ebr.2021.100436

Ejemplares similares